Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Kraig Labs (OTCQB: KBLB) provides additional details regarding the significant advantages of its newly developed immortalized silk gland cell platform
-
Kraig Labs (OTCQB:KBLB) latest breakthrough could form the foundation for a next-generation biotechnology platform with potential applications in biopharma
-
Kraig Biocraft Laboratories (OTCQB:KBLB) has the materials science answer to the global plastics crisis
-
Kraig Biocraft Laboratories (OTCQB: KBLB) successfully commissioned another recombinant spider silk production rearing center.
-
Kraig Labs (OTCQB: KBLB) is the leader in the global race to commercialize spider silk, validated science and advancing production capability.
-
Kraig Labs (OTCQB: KBLB) officially launched its next production cycle following the Company's recent record-setting production run.
-
Kraig Labs (OTCQB: KBLB) two major milestones signal accelerating momentum toward the first successful spider silk commercialization
-
Kraig Biocraft Laboratories (OTCQB: KBLB) is processing its spider silk cocoons into reeled silk.
-
Kraig Biocraft Laboratories, (OTCQB: KBLB) began processing nearly 1.8 metric tons of recombinant spider silk cocoons into finished reeled silk.
-
Ken Paxton’s Lululemon investigation (NASDAQ:LULU) is a wake-up call for the entire synthetic textile industry, as it’s time to move to better fibers like